Antimicrobial resistance and the COVID-19 pandemic.
作者信息
Choudhury Samira, Medina-Lara Antonieta, Smith Richard
机构信息
College of Medicine and Health, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, England.
出版信息
Bull World Health Organ. 2022 May 1;100(5):295-295A. doi: 10.2471/BLT.21.287752.
Abstract
摘要
相似文献
1
Antimicrobial resistance and the COVID-19 pandemic.抗菌药物耐药性与新冠疫情
Bull World Health Organ. 2022 May 1;100(5):295-295A. doi: 10.2471/BLT.21.287752.
2
Has There Been Exacerbation of Disparities in Antimicrobial Resistance during the SARS-Cov-2 Pandemic?在新冠疫情期间，抗菌药物耐药性的差异是否加剧了？
Surg Infect (Larchmt). 2022 Sep;23(7):613-615. doi: 10.1089/sur.2022.099. Epub 2022 Jul 28.
3
Combating antimicrobial resistance during the COVID-19 pandemic.在新冠疫情期间对抗抗菌药物耐药性
Hong Kong Med J. 2021 Dec;27(6):396-398. doi: 10.12809/hkmj215124. Epub 2021 Nov 17.
4
Potential impact of COVID-19 pandemic on escalating antimicrobial resistance in Pakistan.新冠疫情对巴基斯坦抗菌药物耐药性不断升级的潜在影响。
J Infect. 2021 Sep;83(3):e12-e13. doi: 10.1016/j.jinf.2021.07.024. Epub 2021 Jul 28.
5
Antimicrobial resistance vs COVID-19: A bigger challenge in the post-pandemic era!抗微生物药物耐药性与新冠疫情：大流行后时代的一项更大挑战！
J Formos Med Assoc. 2021 Jul;120(7):1537-1538. doi: 10.1016/j.jfma.2021.03.003. Epub 2021 Mar 14.
6
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.大流行后世界的抗菌药物耐药性研究：关于新冠疫情中抗菌药物耐药性研究的见解
J Glob Antimicrob Resist. 2021 Jun;25:5-7. doi: 10.1016/j.jgar.2021.02.013. Epub 2021 Mar 1.
7
Could the COVID-19 pandemic aggravate antimicrobial resistance?新冠疫情会加剧抗菌药物耐药性吗？
Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.
8
Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic.新冠疫情期间急症医院环境中的抗菌药物管理挑战与创新举措
J Antimicrob Chemother. 2021 Jan 1;76(1):272-275. doi: 10.1093/jac/dkaa400.
9
Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.2019 年冠状病毒病与抗菌药物耐药性：平行且相互作用的健康紧急事件。
Clin Infect Dis. 2021 May 4;72(9):1657-1659. doi: 10.1093/cid/ciaa773.
10
Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.评价新冠病毒普通重症监护病房患者气管内抽吸培养物中分离出的细菌，并与大流行前的情况相比，评估其抗生素耐药谱。
Microb Pathog. 2022 Mar;164:105409. doi: 10.1016/j.micpath.2022.105409. Epub 2022 Jan 15.
引用本文的文献
1
Structural Characterisation of TetR/AcrR Regulators in So13.3: An In Silico CRISPR-Based Strategy to Influence the Suppression of Actinomycin D Production.So13.3中TetR/AcrR调控因子的结构表征：一种基于计算机模拟CRISPR的策略，用于影响放线菌素D产量的抑制
Int J Mol Sci. 2025 May 19;26(10):4839. doi: 10.3390/ijms26104839.
2
Improving antibiotic prescribing - Recommendations for funding and pricing policies to enhance use of point-of-care tests.改善抗生素处方开具——关于资助和定价政策以促进即时检验使用的建议
Health Policy Open. 2024 Sep 28;7:100129. doi: 10.1016/j.hpopen.2024.100129. eCollection 2024 Dec 15.
3
Outpatient antibiotic prescribing during the first two years of the COVID-19 pandemic: A nationwide register-based time series analysis.COVID-19 大流行的头两年的门急诊抗生素处方：一项基于全国登记的时间序列分析。
PLoS One. 2023 Dec 18;18(12):e0296048. doi: 10.1371/journal.pone.0296048. eCollection 2023.
4
Response to antimicrobial resistance in South-East Asia Region.东南亚地区对抗菌素耐药性的应对措施。
Lancet Reg Health Southeast Asia. 2023 Oct 29;18:100306. doi: 10.1016/j.lansea.2023.100306. eCollection 2023 Nov.
5
Recent Progress in Stimuli-Responsive Antimicrobial Electrospun Nanofibers.刺激响应型抗菌电纺纳米纤维的最新进展
Polymers (Basel). 2023 Nov 1;15(21):4299. doi: 10.3390/polym15214299.
6
Knowledge, Attitudes, and Practices Regarding Antibiotic Use and Resistance: A Cross-Sectional Study among Students in Israel.关于抗生素使用与耐药性的知识、态度和行为：以色列学生的横断面研究
Antibiotics (Basel). 2023 Jun 8;12(6):1028. doi: 10.3390/antibiotics12061028.
7
Dynamic associations between the respiratory tract and gut antibiotic resistome of patients with COVID-19 and its prediction power for disease severity.新冠患者呼吸道和肠道抗生素耐药组的动态关联及其对疾病严重程度的预测能力。
Gut Microbes. 2023 Jan-Dec;15(1):2223340. doi: 10.1080/19490976.2023.2223340.
8
Flare of the silent pandemic in the era of the COVID-19 pandemic: Obstacles and opportunities.新冠疫情时代隐匿性大流行的爆发：障碍与机遇
World J Clin Cases. 2023 Feb 26;11(6):1267-1274. doi: 10.12998/wjcc.v11.i6.1267.
9
A cross-sectional study of hospital antimicrobial stewardship programmes in the COVID-19 era.COVID-19 时代医院抗菌药物管理计划的横断面研究。
JAC Antimicrob Resist. 2022 Dec 29;5(1):dlac134. doi: 10.1093/jacamr/dlac134. eCollection 2023 Feb.
10
The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review.2019年冠状病毒病对引起医疗保健相关感染的多重耐药菌的影响：一项叙述性综述。
JAC Antimicrob Resist. 2022 Dec 29;5(1):dlac130. doi: 10.1093/jacamr/dlac130. eCollection 2023 Feb.
本文引用的文献
1
Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.新冠疫情对抗菌药物耐药性监测、预防和控制的影响：全球调查。
J Antimicrob Chemother. 2021 Oct 11;76(11):3045-3058. doi: 10.1093/jac/dkab300.
2
CON: COVID-19 will not result in increased antimicrobial resistance prevalence.反对观点：新型冠状病毒肺炎不会导致抗菌药物耐药性患病率上升。
JAC Antimicrob Resist. 2020 Sep;2(3):dlaa051. doi: 10.1093/jacamr/dlaa051. Epub 2020 Jul 17.
3
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance.关于 COVID-19 大流行对抗菌药物耐药性研究和监测的潜在影响的关键考虑因素。
Trans R Soc Trop Med Hyg. 2021 Oct 1;115(10):1122-1129. doi: 10.1093/trstmh/trab048.
4
Antimicrobial resistance and COVID-19: Intersections and implications.抗微生物药物耐药性与 COVID-19：交叉与影响。
Elife. 2021 Feb 16;10:e64139. doi: 10.7554/eLife.64139.
5
What role for One Health in the COVID-19 pandemic?在新冠疫情中，“One Health”（同一健康）应发挥什么作用？
Can J Public Health. 2020 Oct;111(5):641-644. doi: 10.17269/s41997-020-00409-z. Epub 2020 Sep 9.
6
Global Antimicrobial Stewardship with a Focus on Low- and Middle-Income Countries.全球抗菌药物管理：关注中低收入国家
Int J Infect Dis. 2020 Jul;96:621-629. doi: 10.1016/j.ijid.2020.05.126. Epub 2020 Jun 4.
7
The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex 'mix-and-match' implementation package.快速传染病和抗菌药物耐药性床边检测的成功采用和可持续性需要一个复杂的“混合搭配”实施包。
Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1015-1022. doi: 10.1007/s10096-019-03492-4. Epub 2019 Feb 2.
Zotero 插件